Moderna
MRNA
#1471
Rank
NZ$20.84 B
Marketcap
$54.02
Share price
-2.23%
Change (1 day)
-65.65%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$20.84 Billion

As of March 2025 Moderna has a market cap of NZ$20.84 Billion. This makes Moderna the world's 1471th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$20.84 B-23.88%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Mar 3rd, 2025 the market cap of Moderna was reported to be:

NZ$20.84 Billion
by Yahoo Finance info icon info icon
NZ$20.84 Billion
by CompaniesMarketCap info icon info icon
NZ$20.84 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.14 B-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$419.94 B 1,914.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.48 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$56.26 B 169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$389.92 B 1,770.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$3.98 B-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$718.78 B 3,348.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.31 B-74.50%๐Ÿ‡บ๐Ÿ‡ธ USA